Trials / Recruiting
RecruitingNCT03810768
Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
Metabolomics Pilot Study on Postoperative Intensive Care Acquired Muscle Weakness (MIRACLE-I Study)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- Technical University of Munich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
In this mono-center pilot trial, surgical patients who are at high risk to be admitted to intensive care will be screened and asked for participation. We are going to take blood and muscle samples at respecified time points to do metabolic, histological and molecular testing. Aim of the study is to investigate (1) changes of the blood metabolome in patients with ICUAW (intensive care unit acquired weakness) and (2) identify metabolic components who are responsible for ICUAW or can be used as marker for ICUAW.
Conditions
- Metabolomics
- Critical Care
- Critical Illness
- Critical Illness Myopathy
- Critical Illness Polyneuropathy
- Intensive Care (ICU) Myopathy
- Muscle Weakness
Timeline
- Start date
- 2022-09-02
- Primary completion
- 2026-11-01
- Completion
- 2026-12-31
- First posted
- 2019-01-22
- Last updated
- 2026-03-03
Locations
3 sites across 2 countries: Austria, Germany
Source: ClinicalTrials.gov record NCT03810768. Inclusion in this directory is not an endorsement.